CARGO Therapeutics, Inc. (CRGX)
(Delayed Data from NSDQ)
$16.72 USD
-0.46 (-2.68%)
Updated Jun 14, 2024 04:00 PM ET
After-Market: $16.65 -0.07 (-0.42%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CRGX 16.72 -0.46(-2.68%)
Will CRGX be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CRGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRGX
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High?
CRGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for Mar 25, 2024
Alexandria (ARE) to Post Q4 Earnings: What's in the Cards?
Alexandria (ARE) Inks Leases at its Campuses Amid Solid Demand
Other News for CRGX
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment of Jane Pritchett Henderson as Independent Director
Insider Trading: Cargo Therapeutics’ Insider Buys Shares Worth $5M
$4M Bet On This Health Care Stock? Check Out These 3 Stocks Insiders Are Buying
CARGO Therapeutics Bolsters Board and Affirms Auditor Engagement
Undiscovered Stocks on the Verge of a Breakout: 3 Names to Know Now